Skip to search formSkip to main contentSkip to account menu

Codependency Assessment Inventory

Known as: CDAI 
National Institutes of Health

Related topics

Related topics

2 relations

Narrower (1)

FCAI

Broader (1)

Personality inventories

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2014
Highly Cited
2014
A phase 2 study of allogeneic mesenchymal stromal cells for luminal Crohn's disease refractory to biologic therapy.
Highly Cited
2008
Highly Cited
2008
Treatment of active Crohn's disease with MLN0002, a humanized antibody to the alpha4beta7 integrin.
Highly Cited
2004
Highly Cited
2004
A pilot randomized trial of a human anti-interleukin-6 receptor monoclonal antibody in active Crohn's disease.
BACKGROUND & AIMS Interleukin-6 (IL-6) regulates immune response and inflammation. We carried out a pilot placebo-controlled… 
Highly Cited
2002
Highly Cited
2002
Double blind, placebo controlled trial of the remission inducing and steroid sparing properties of an ICAM-1 antisense oligodeoxynucleotide, alicaforsen (ISIS 2302), in active steroid dependent Crohn…
Background and aims: To evaluate the safety and efficacy of the intercellular adhesion molecule 1 (ICAM-1) antisense… 
Highly Cited
2001
Highly Cited
2001
A randomized placebo-controlled trial of a humanized monoclonal antibody to α4 integrin in active crohn's disease
Abstract Background & Aims: α4 integrins are important mediators of leukocyte migration across vascular endothelium.This pilot… 
Highly Cited
2001
Highly Cited
2001
Absence of efficacy of subcutaneous antisense ICAM-1 treatment of chronic active Crohn's disease.
BACKGROUND & AIMS ISIS-2302, an antisense oligonucleotide directed against intercellular adhesion molecule 1, was effective in… 
Highly Cited
2000
Highly Cited
2000
Ultrasound in Crohn's disease of the small bowel.
Highly Cited
2000
Highly Cited
2000
Polymeric versus elemental diet as primary treatment in active Crohn's disease: a randomized, double-blind trial
OBJECTIVE:Enteral feeding is now an established primary therapy for active Crohn's disease. This first-double blind randomized… 
Highly Cited
1999
Highly Cited
1999
A controlled trial comparing ciprofloxacin with mesalazine for the treatment of active Crohn's disease
OBJECTIVE:The aim of this randomized controlled study was to investigate the efficacy of ciprofloxacin compared with mesalazine… 
Highly Cited
1998
Highly Cited
1998
Randomised trial of mycophenolate mofetil versus azathioprine for treatment of chronic active Crohn’s disease
BACKGROUND Crohn’s disease is a chronic inflammatory disease of the alimentary tract. Azathioprine is an effective agent in the… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)